Role of sodium and calcium channel block in unmasking the Brugada syndrome
Section snippets
Methods
The detailed methods employed for isolation, perfusion, and recording of transmembrane activity from the arterially perfused canine right ventricular (anterior wall) wedge preparation, as well as the viability and electrical stability of the preparation, have been previously reported. Experiments demonstrating that activity recorded from the cut surface of the perfused wedge preparation is representative of cells within the respective layers of the wall throughout the wedge have also been
Results
The ability of combined INa and ICa block to cause loss of the epicardial action potential dome and phase 2 reentry in the canine right ventricular wedge preparation is illustrated in Figure 1. High concentrations of terfenadine, in this case 5 μM, produced an accentuation of the epicardial action potential notch following acceleration of the rate from a BCL of 800 ms to 400 ms. The dramatic accentuation of the notch was due to the effect of the drug to depress phase 0, augment the magnitude
Discussion
Mutations in SCN5A associated with a loss of function of the sodium channel have been shown to underlie some forms of the Brugada syndrome. Linkage to SCN5A is consistent with the clinical finding that potent sodium channel blockers, including Class IC antiarrhythmic agents such as flecainide, ajmaline, or pilsicainide, or Class IA agents such as procainamide and disopyramide, can unmask the Brugada syndrome when the electrocardiographic phenotype is concealed.3, 4, 18 These findings prompted
Clinical implications
Our data demonstrate that terfenadine can induce loss of the epicardial action potential dome, phase 2 reentry, and resulting polymorphic ventricular tachycardia and fibrillation in the canine right ventricular wedge, highlighting the potential adverse effects of agents with combined sodium and calcium channel blocking effects. Whether terfenadine itself may be useful as a diagnostic tool is questionable because of its actions to block the rapidly activating delayed rectifier current, IKr, at
Study limitation
As with all basic studies involving animal experimentation, we must exercise caution in extrapolating these findings to the clinic. Although inhibition of INa and ICa by terfenadine generates electrocardiographic characteristics and arrhythmic manifestations very similar to those observed clinically, to what extent this model mimics the various forms of congenital and acquired Brugada syndrome remains to be established.
Acknowledgements
Supported by grant HL47678 from NHLBI (CA) and grants from the American Heart Association (JF and CA) and NYS and Florida Grand Lodges F. & A.M.
We gratefully acknowledge the expert technical assistance of Judy Hefferon, Robert Goodrow, Di Hou, and Andrew Pitoniak.
References (34)
- et al.
Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report
J Am Coll Cardiol
(1992) - et al.
Genotype-phenotype relationship in Brugada syndromeelectrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients
J Am Coll Cardiol
(2002) - et al.
Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome
J Am Coll Cardiol
(1996) - et al.
Sudden death in high-risk family membersBrugada syndrome
Am J Cardiol
(2000) - et al.
Cellular and ionic mechanisms responsible for the Brugada syndrome
J Electrocardiol
(2000) Late potentials and the Brugada syndrome
J Am Coll Cardiol
(2002)- et al.
Antiarrhythmic actions of antihistamines
Pharmacol Ther [B]
(1976) - et al.
Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts
Circulation
(2000) - et al.
Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndromeA prospective evaluation of 52 families
Circulation
(2000) - et al.
Cellular basis for the Brugada Syndrome and other mechanisms of arrhythmogenesis associated with ST segment elevation
Circulation
(1999)